do oral semaglutide drops work GLP-1 Analogues (Semaglutide) Oral Semaglutide Tablets & Drops

Description

Obesity is a chronic condition, characterised by excessive fat, which increases the risk of serious diseases such as type 2 diabetes

The Study: Real-World Weight Loss Outcomes Researchers analyzed data from over 50,000 adults with obesity: 38,545 patients received a GLP-1 medication such as semaglutide or tirzepatide 12,540 patients underwent bariatric surgery, primarily gastric bypass or sleeve gastrectomy Key Findings : Surgery patients lost an average of 24% of their body weight over two years about 58 pounds

Specifically, semaglutide is approved for individuals with a body mass index (BMI) of 30 or higher (classified as obese) or a BMI of 27 with at least one weight-related health condition such as high blood pressure, type 2 diabetes, or high cholesterol

FDA-Approved vs Compounded GLP-1 Medications Understanding the regulatory difference between FDA-approved GLP-1 medications and compounded GLP-1 formulations is essential for individuals researching weight loss treatments in 2026